Cargando…
Elucidating the Importance of DOT1L Recruitment in MLL-AF9 Leukemia and Hematopoiesis
SIMPLE SUMMARY: MLL-rearranged leukemia, driven by MLL-fusion proteins, is an aggressive, therapy-resistant leukemia found in >60% of infant leukemia and ~10% of adult leukemia. Studies have shown that inhibiting DOT1L enzymatic activity blocks leukemogenesis. However, DOT1L is critical for vario...
Autores principales: | Grigsby, Sierrah M., Friedman, Ann, Chase, Jennifer, Waas, Bridget, Ropa, James, Serio, Justin, Shen, Chenxi, Muntean, Andrew G., Maillard, Ivan, Nikolovska-Coleska, Zaneta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914713/ https://www.ncbi.nlm.nih.gov/pubmed/33562706 http://dx.doi.org/10.3390/cancers13040642 |
Ejemplares similares
-
p38-mediated phosphorylation at T367 induces EZH2 cytoplasmic localization to promote breast cancer metastasis
por: Anwar, Talha, et al.
Publicado: (2018) -
Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening
por: Mady, Ahmed S. A., et al.
Publicado: (2018) -
Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair
por: Castaño, Julio, et al.
Publicado: (2016) -
The PAF Complex Regulation of Prmt5 Facilitates the Progression and Maintenance of MLL-Fusion Leukemia
por: Serio, Justin, et al.
Publicado: (2017) -
Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition
por: Chen, Lili, et al.
Publicado: (2015)